KEY FEATURES
| Full Name | Hypoxia Inducible Factor 1 Alpha |
|---|---|
| Synonym | HIF1A;HIF-1A;MOP1;PASD8;bHLHe78;basic helix-loop-helix transcription factor; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 62.5-4000pg/mL |
| Sensitivity | 37.5pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human HIF-1α in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human HIF-1α. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human HIF-1α and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human HIF-1α, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human HIF-1α. You can calculate the concentration of Human HIF-1α in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human HIF-1α ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 220.27 | 512.73 | 1511.71 | 202.89 | 474.45 | 1444.98 |
| Standard deviation | 14.93 | 29.28 | 65.91 | 10.49 | 26.47 | 62.13 |
| CV(%) | 6.78 | 5.71 | 4.36 | 5.17 | 5.58 | 4.3 |
RECOVERY
The recovery of Human HIF-1α spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-103 | 97 |
| EDTA plasma (n=8) | 87-102 | 95 |
| Cell culture media (n=8) | 88-101 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human HIF-1α in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with ARNT ELISA Kits
| AHR ELISA Kit | publications with ARNT and AHR |
| HIF1A ELISA Kit | publications with ARNT and HIF1A |
| SIM1 ELISA Kit | publications with ARNT and SIM1 |
| HIF3A ELISA Kit | publications with ARNT and HIF3A |
| VEGFA ELISA Kit | publications with ARNT and VEGFA |
| SIM2 ELISA Kit | publications with ARNT and SIM2 |
| EPAS1 ELISA Kit | publications with ARNT and EPAS1 |
| AKT1 ELISA Kit | publications with ARNT and AKT1 |
| EP300 ELISA Kit | publications with ARNT and EP300 |
| LDHA ELISA Kit | publications with ARNT and LDHA |
Pathways associated with ARNT ELISA Kit
| AhR Pathway | AhR Pathway |
| Angiogenesis Pathway | Angiogenesis Pathway |
| Cellular Response To Hypoxia Pathway | Cellular Response To Hypoxia Pathway |
| Cellular Responses To Stress Pathway | Cellular Responses To Stress Pathway |
| Chemical Carcinogenesis Pathway | Chemical Carcinogenesis Pathway |
| HIF-1 Signaling Pathway | HIF-1 Signaling Pathway |
| HIF-1-alpha Transcription Factor Network Pathway | HIF-1-alpha Transcription Factor Network Pathway |
| HIF-2-alpha Transcription Factor Network Pathway | HIF-2-alpha Transcription Factor Network Pathway |
| Hypoxic And Oxygen Homeostasis Regulation Of HIF-1-alpha Pathway | Hypoxic And Oxygen Homeostasis Regulation Of HIF-1-alpha Pathway |
Diseases associated with ARNT ELISA Kit
| Liver Diseases | publications with ARNT and Liver Diseases |
| Liver Neoplasms | publications with ARNT and Liver Neoplasms |
| Cardiovascular Diseases | publications with ARNT and Cardiovascular Diseases |
| Nervous System Diseases | publications with ARNT and Nervous System Diseases |
| Carcinoma, Hepatocellular | publications with ARNT and Carcinoma, Hepatocellular |
| Neoplasms, Experimental | publications with ARNT and Neoplasms, Experimental |
| Breast Neoplasms | publications with ARNT and Breast Neoplasms |
| Inflammation | publications with ARNT and Inflammation |
| Liver Neoplasms, Experimental | publications with ARNT and Liver Neoplasms, Experimental |
| Necrosis | publications with ARNT and Necrosis |
Organs/Tissues associated with ARNT ELISA Kit
| Liver | publications with ARNT and Liver |
| Brain | publications with ARNT and Brain |
| Blood | publications with ARNT and Blood |
| Vascular | publications with ARNT and Vascular |
| Muscle | publications with ARNT and Muscle |
| Heart | publications with ARNT and Heart |
| Lung | publications with ARNT and Lung |
| Kidney | publications with ARNT and Kidney |
| Embryonic Tissue | publications with ARNT and Embryonic Tissue |
| Ovary | publications with ARNT and Ovary |